American Society of Hematology

SHERPA: Blue

People

  1. Chung
    Chung
  2. Landau
    Landau
  3. Giralt
    Giralt
  4. Lesokhin
    Lesokhin
  5. Hassoun
    Hassoun
  6. Korde
    Korde
  7. Shah
    Shah
  8. Mailankody
    Mailankody
  9. Devlin
    Devlin
  10. Scordo
    Scordo

Groups

  1. Bone Marrow Transplant (75)
  2. Center for Hematologic Malignancies (75)
  3. Department of Medicine (75)
  4. Hematologic Malignancies, Division of (75)
  5. Survivorship Research (67)
  6. Myeloma (61)
  7. Hematologic Malignancies Research (59)
  8. Epidemiology and Biostatistics (52)
  9. Biostatistics Service (48)
  10. CTCR Scholars (37)
Search Within
  1. "David Chung"
Formats
  1. Meeting Abstract (67)
  2. Journal Article (8)
Groups
  1. Bone Marrow Transplant (75)
  2. Center for Hematologic Malignancies (75)
  3. Department of Medicine (75)
  4. Hematologic Malignancies, Division of (75)
  5. Survivorship Research (67)
  6. Myeloma (61)

More Groups

People
  1. David Chung (75)
  2. Heather Landau (64)
  3. Sergio Giralt (63)
  4. Alexander Lesokhin (56)
  5. Hani Hassoun (52)
  6. Neha Korde (39)

More People

Years
  1. 2023 (10)
  2. 2022 (11)
  3. 2021 (7)
  4. 2020 (5)
  5. 2019 (3)
  6. 2018 (8)

More Years

Publications
  1. Blood (73)
  2. Blood Advances (2)

Results (75)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Carfilzomib,lenalidomide and dexamethasone (KRd) as induction therapy in high-risk newly diagnosed multiple myeloma
    Meeting Abstract

    Tan, C.; Korde, N.; Derkach, A.; Hultcrantz, M.; Maclachlan, K. H.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Patel, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy
    Meeting Abstract

    Hamadeh, I. S.; Shekarkhand, T.; Rueda, C.; Firestone, R.; Wang, A.; Korde, N.; Hultcrantz, M.; Lesokhin, A.; Mailankody, S.; Hassoun, H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Evaluating the effect of evolving changes in serum biomarkers on the risk of progression in smoldering multiple myeloma
    Meeting Abstract

    Akhlaghi, T.; Nemirovsky, D.; Maclachlan, K. H.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Patel, D.; Shah, U. A.; Tan, C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Stem cell utilization in the era of novel therapies for multiple myeloma
    Meeting Abstract

    Nishimura, N.; Nemirovsky, D.; Devlin, S. M.; Dahi, P. B.; Landau, H.; Lahoud, O. B.; Scordo, M.; Shah, G. L.; Mailankody, S.; Hassoun, H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A comparative analysis of infectious complications in patients with multiple myeloma treated with BCMA-targeted bispecific antibodies and CAR T-cell therapy
    Meeting Abstract

    Nath, K.; Shekarkhand, T.; Costa, B. A.; Nemirovsky, D.; Derkach, A.; Nishimura, N.; Farzana, T.; Rueda, C.; Chung, D.; Landau, H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical outcomes associated with del(17p) in newly diagnosed multiple myeloma treated with triplet and daratumumab-based quadruplet induction regimens
    Meeting Abstract

    Jurgens, E.; Firestone, R.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Evaluating tumor-intrinsic and patient-specific mechanisms of resistance to teclistamab in anti-BCMA exposed and naïve multiple myeloma
    Meeting Abstract

    Firestone, R.; McAvoy, D.; Shekarkhand, T.; Serrano, E.; Hamadeh, I. S.; Wang, A.; Zhu, M.; Patel, D.; Tan, C.; Hultcrantz, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Low target antigen expression mediates resistance to BCMA CAR T cell therapy
    Meeting Abstract

    Perica, K.; Nataraj, S.; Sjojstrand, M. L.; Nagel, K.; Pavkovic, E.; Payson, E.; Cuenca, A.; Patel, A.; Chung, D.; Mailankody, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures
    Journal Article

    Diamond, B.; Ziccheddu, B.; Maclachlan, K.; Taylor, J.; Boyle, E.; Ossa, J. A.; Jahn, J.; Affer, M.; Totiger, T. M.; Coffey, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Gilbert, L. J.; Hanley, D. M.; Flynn, J. R.; Devlin, S. M.; Nguyen, L. K.; Ruiz, J. D.; Shah, G. L.; Sauter, C. S.; Chung, D. J.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save